Quick Answer
Ginkgo Bioworks Holdings, Inc. reported Total Revenue of $170.16 million for fiscal year 2025.
Ginkgo Bioworks Holdings, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $170.16M | -25.1% |
| 2024 | $227.04M | -9.7% |
| 2023 | $251.46M | -47.4% |
| 2022 | $477.71M | +52.2% |
| 2021 | $313.84M | +309.4% |
| 2020 | $76.66M | +41.5% |
| 2019 | $54.18M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $38.84M | -56.4% | -21.7% |
| June 30, 2025 | $49.60M | -11.7% | +2.7% |
| March 31, 2025 | $48.32M | +27.3% | -45.7% |
| September 30, 2024 | $89.05M | +60.6% | +58.4% |
| June 30, 2024 | $56.21M | -30.2% | +48.1% |
| March 31, 2024 | $37.94M | -53.0% | -31.5% |
| September 30, 2023 | $55.43M | -16.5% | -31.2% |
| June 30, 2023 | $80.57M | -44.3% | -0.2% |
- Ginkgo Bioworks Holdings, Inc. showed a decrease of -25.1% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Ginkgo Bioworks Holdings, Inc.’s total revenue has grown by 214.0% (from $54.18 million to $170.16 million).
- The most recent figure is from Ginkgo Bioworks Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: